Press Releases

TORONTO, Aug. 26, 2019 /PRNewswire/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company") the first and only cannabis company licensed for sales in Canada, the US, and the EU, today announced it has received approval for Depository Trade Clearance (DTC) settlement services. DTC is a subsidiary of

SAN FRANCISCO, Aug. 26, 2019 /PRNewswire/ -- Audentes Therapeutics, Inc. (Nasdaq: BOLD), a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases, today announced that it will participate in the following investor conferences in September: Citi's

BOSTON, Aug. 26, 2019 /PRNewswire/ -- Iora Primary Care today announced the opening of five practices in North Carolina providing high quality primary care to older adults on Medicare. The locations will open in Fall 2019 with two sites in Charlotte and three in the Triad (Winsto

ZUG, Switzerland, Aug. 26, 2019 /PRNewswire/ -- This is a fundamental re-engineering of our award-winning first and only smart watch with an Automatic Self-Charging battery system, providing world record power autonomy. It has groundbreaking features, because the more you move, the more you transform 100% clean kinetic energy int

SAN DIEGO, Aug. 26, 2019 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced Marty Duvall, chief executive

DENVER, Aug. 26, 2019 /PRNewswire/ -- CBD of Denver, Inc. (OTC CBDD) is pleased to announce the relaunch of our E-Commerce Web Site www.blackpearlcbd.com.  The website w

SAN DIEGO, Aug. 26, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis), for the treatment of various cancers including prostate, colorectal and leukemia, today announced the presentation of positive clinical data f

SAN DIEGO, Aug. 26, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will participate in the 2019 Wells Fargo Healthcare Conference in Boston, MA.  Dr. Helen Torley, president and chief executive officer

HOUSTON, Aug. 26, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that it has engaged argodesign, an award-winnin

AUSTIN, Texas, Aug. 26, 2019 /PRNewswire/ -- Leading health and wellness solutions provider, Salutoceuticals, LLC, announced the launch of their new Sleep Remedy formula designed for more effectiveness and efficiency.